Home » Topics » Regulatory » Patents

Patents
RSS

Cysteine protease-inhibitory peptides disclosed by Takeda

March 2, 1999

Naturally occurring inhibitors of cathepsins discovered at Sankyo

March 2, 1999

Agents for diabetes, impotence, lipid and cardiovascular disorders from Fujisawa

March 2, 1999

AHP describes new dopamine autoreceptor agonists in patent literature

March 2, 1999

New MMP and/or TNF production inhibitors developed by Pfizer research group

March 2, 1999

ADIR patents new ellipticine/olivacine derivatives with excellent antitumor activity

March 2, 1999

Merck & Co.'s new thrombin inhibitors

March 1, 1999

French investigators describe potent and selective dopamine D3 agonists

March 1, 1999

Novo Nordisk discloses new potassium channel modulators and use in endocrine and other disorders

March 1, 1999

Antiplatelet agents under research at Monsanto

March 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...